The anaplastic lymphoma kinase (ALK) is a transmembrane receptor tyrosine kinase involved in the pathogenesis of different types of human cancers, including anaplastic large-cell lymphoma, neuroblastoma and non-small cell lung cancer (NSCLC) [1–4]. This evidence concerns the gene ALK and neuroblastoma.